Interested in clinical or scientific research collaboration: Contact us
Commensal Postbiotics:
Bactana has optimized the isolation and formulation of some of the most difficult to grow anaerobic bacteria found in animals. The role of these commensal bacteria has been well documented in metabolism, immune response, and gut health, yet harnessing their therapeutic potential has been elusive. Until now.
Bactana is the only company in the world with an approved and patented product derived from F. prausnitzii (currently approved by Health Canada for sales in Canada).
SMART SUSTAINABLE SOLUTIONS
The gut microbiota has an essential role in many aspects of life, including metabolism and the development of a healthy immune system. Bactana develops innovative products from molecules expressed from proprietary anaerobic bacteria cell lines.
Rapid advances in molecular methods and DNA sequencing used to study microbial ecology have greatly facilitated the ability of scientists to understand the role of microorganisms at an accelerating pace. Bactana’s researchers are at the forefront of applying this science to the animal health field and are dedicated to developing products that are safe, sustainable, improve the lives of companion animals, and promote sustainable production for livestock producers.
Please contact us if you would like to learn more about our product initiatives or to explore collaboration opportunities.
Harnessing the Power of
the Microbiome
Supporting Trials
-
In several trials, extracts from our proprietary postbiotics reduced blood glucose levels, percent HbA1c, and improved glucose tolerance in diabetic and prediabetic mice. Repeated treatment was also found to prevent obese, diet induced mice from developing diabetes. In healthy mice, our postbiotics did not lead to reduction of blood glucose below normal levels—no hypoglycemia, a common side effect of many current diabetic therapies.
For more information Contact Us
-
Oral administration of Faecalibacterium prausnitzii (FP) decreased the incidence of severe diarrhea in dairy calves, with a 47% reduction in Scours and related mortality rate reduction of 66% in calves with severe diarrhea. FP treatment also led to improved weight gain in preweaned dairy heifers with a 13.2% increase compared to control calves.
-
Broiler chicks treated with Bactana’s proprietary postbiotic extract were found to have a significantly improved lifetime feed conversion ratio, higher market weight, and meat yield compared to broilers not treated.
For more information Contact Us
-
Cats treated with our proprietary postbiotics were found to have improved indicators of gut health compared to untreated cats.
For more information Contact Us.